Cellares signed a collaboration with City of Hope to evaluate its Cell Shuttle manufacturing platform and Cell Q quality‑control automation for City of Hope’s CARpool program targeting glioblastoma. The collaboration aims to standardize and scale manufacturing for a solid‑tumor CAR T—the field’s most challenging deployment—by building automation and analytics into processes at preclinical stages. City of Hope emphasized the need for reproducible, high‑throughput manufacturing to translate solid‑tumor CAR Ts to larger patient populations; Cellares highlighted automation’s role in lowering failure rates and expanding access.